Breach of Privacy with Patient Prescription Drug Profiles: Confidential quality assurance/quality initiative prescription drug profiles should not be provided by pharmaceutical companies to their marketing staff or other unauthorized persons for marketing purposes. The Texas Medical Association voted to seek legislative controls to prohibit the use of this patient drug information in the marketing of pharmaceutical companies (Res. 409-I-98; reaffirmed CSA Rep. 2-I-01; reaffirmed CSPH Rep. 3-A-11).
Last Updated On
October 07, 2016